← Back to the education center

IVF Process & Technology

What medications are used in IVF treatment: injections, the trigger shot and progesterone explained

A plain-language guide to the main medication groups used in an IVF cycle - stimulation injections, ovulation-blocking medicines, the trigger shot and progesterone - and why every prescribing decision belongs with a licensed physician.

What medications are used in IVF treatment: injections, the trigger shot and progesterone explained educational image

For many people, the medication schedule is the most unfamiliar part of an IVF cycle - a stretch of daily injections, precise timings and new hormone names that can feel overwhelming before it has even begun. The medicines themselves fall into a small number of groups with clear jobs: stimulating the ovaries to grow several eggs at once, preventing those eggs from being released too early, maturing them at exactly the right moment, and supporting the lining of the womb afterwards. Understanding what each group does can make the process feel far less mysterious. What this article cannot do is say which medicines, at what strength, are right for any individual - protocols differ from person to person and cycle to cycle, and those decisions always belong to a licensed physician who knows the full medical picture.

What medications are used during an IVF cycle?

Most IVF cycles draw on a handful of medication groups, each with a distinct role. The core group is the gonadotropins - the ASRM fact sheet describes these as fertility medications given by injection that contain follicle-stimulating hormone, either alone or combined with luteinising hormone, working directly on the ovaries so that multiple follicles develop rather than the single one a natural cycle usually produces. Alongside them sit medicines that stop the body ovulating before egg retrieval, known as GnRH agonists and GnRH antagonists. A trigger injection - often hCG - is used to complete egg maturation at a precisely chosen time, and progesterone supports the womb lining after retrieval and embryo transfer. Some clinics also use oral tablets such as clomiphene citrate or letrozole in certain milder protocols; the ASRM notes that clomiphene works by prompting the pituitary gland to make more of the body's own follicle-stimulating hormone, while letrozole temporarily lowers estradiol so the pituitary responds in a similar way. Which of these a clinic combines, and in what order, is a protocol decision made by a licensed physician - there is no single standard recipe.

How are IVF injections given, and can I do them myself at home?

The HFEA, the UK fertility regulator, describes gonadotrophins simply as hormones that are injected into the body to help stimulate egg production, and notes that the medicines used to suppress natural hormones may be given as a daily injection or a nasal spray. In everyday practice, clinics teach patients or their partners to give most of these injections at home, usually into the fatty tissue just under the skin of the abdomen or thigh using very fine, short needles supplied as pre-filled pens or small vials. Nurses typically demonstrate the technique at the start of a cycle, and many people who were nervous at first find the routine manageable within a few days. That said, technique, storage and timing all matter, and instructions differ between products and protocols - so the only reliable guidance on how and when to give a specific medicine comes from the prescribing clinic. Anyone unsure about an injection they are about to give should contact their clinic or a licensed physician rather than guessing, and should never change how a medicine is taken on their own initiative.

How many injections does IVF involve, and for how long?

There is no fixed number, and any article that promises one is oversimplifying. The overall shape is that ovarian stimulation usually involves daily injections continuing over a period of days to a couple of weeks, with the clinic checking progress as it goes - the HFEA notes that during stimulation a person is closely monitored by the clinic, which may involve blood tests or ultrasound scans, and that the hormone treatment, usually a gonadotrophin, is started to boost the number of eggs the body produces. Depending on the protocol, a second daily injection may be added to prevent early ovulation, and a single trigger injection comes near the end. Progesterone afterwards is often not an injection at all - the HFEA describes it as usually a pessary or gel that a person can insert themselves. The exact count therefore depends on the protocol chosen, how the ovaries respond, and how long each phase runs for that individual. Because doses and durations are adjusted in response to monitoring, only the treating licensed physician can say what a particular cycle will involve - and even then, plans commonly change mid-cycle as scan results come in.

Why do some IVF medications prevent early ovulation?

Stimulating the ovaries creates a problem the medication plan has to solve: as follicles grow, the body may try to release the eggs on its own schedule, before the clinic can collect them. If that happened, the eggs would be lost into the body and the retrieval procedure would have nothing to retrieve. To prevent this, protocols include a medicine from the GnRH agonist or GnRH antagonist class. The ASRM explains that these prevent spontaneous ovulation by suppressing the body's own follicle-stimulating and luteinising hormone signals - with an important difference between the two classes: agonists cause an initial rise in those hormones before suppression sets in, while antagonists suppress them immediately. That difference is one reason protocols are structured differently - an agonist is typically started earlier, whereas an antagonist can be added partway through stimulation, an approach the HFEA also describes as taking an antagonist to suppress hormones for a few days after the stimulation medicine has begun. Which approach suits a given person depends on their history, hormone levels and previous responses, which is exactly the kind of judgement that belongs to a licensed physician rather than a general article.

What does the trigger shot do, and why is its timing so important?

The trigger shot is the pivot point of the whole stimulation phase. In a natural cycle, a surge of luteinising hormone from the brain tells the mature follicle to complete the final maturation of its egg and release it. In IVF, that natural surge has usually been suppressed on purpose, so the clinic replaces it with a single injection - the ASRM states that an injection of hCG mimics the natural luteinising hormone surge and causes the follicle to release its egg. Clinics use this predictability to schedule egg retrieval a set number of hours after the trigger, aiming to collect the eggs when they are mature but before the ovaries release them. This is why trigger instructions are unusually precise about the clock time of the injection - giving it early or late shifts the whole retrieval window. In some situations a physician may choose a different trigger medicine; the ASRM OHSS fact sheet lists changing the trigger medicine as one of the strategies used when the risk of over-response is a concern. One practical detail worth knowing from the ASRM: hCG can linger in the body and affect a pregnancy test taken soon after the injection, another reason to follow the clinic's testing instructions exactly.

Why is progesterone taken after egg retrieval and embryo transfer?

Progesterone is the hormone that prepares and maintains the lining of the womb so that an embryo can implant and be supported in early pregnancy. In a natural cycle it is produced by the ovary after ovulation, but IVF medication and the egg retrieval procedure can disrupt that natural production, so clinics routinely prescribe progesterone support - often called luteal support - from around the time of retrieval and continuing after embryo transfer. The HFEA describes this step plainly: medication helps to prepare the lining of the womb, and it is usually taken as a pessary or gel that a person can insert themselves, though some clinics use injections or other forms instead. How long progesterone continues varies between clinics and between fresh and frozen transfer plans, and stopping it is a decision with real consequences for the cycle - which is why patients are asked never to stop or change luteal support on their own, even if a test result is disappointing, without speaking to their licensed physician first. Anyone confused about their progesterone instructions, or experiencing problems with the form they have been given, should raise it with the clinic, as alternatives often exist within the same class.

What side effects are common with IVF medications, and when do they go away?

Most side effects of IVF medication are the predictable result of shifting hormone levels, and most settle once the medicines stop. The ASRM fact sheet on injectable fertility drugs states that some women experience breast tenderness, headaches, mood swings and local skin irritation at injection sites. The HFEA lists a broadly similar picture for fertility drugs, including stomach pains or a bloated stomach, hot flushes, mood swings, breast tenderness, headaches and insomnia among possible effects. Medicines that suppress the body's own hormones can produce temporary menopause-like symptoms - the ASRM notes hot flashes, mood swings and vaginal dryness with longer use of GnRH agonists. Injection-site redness or small bruises are common and usually short-lived, and rotating the injection area is a standard piece of clinic advice. Two general principles are worth holding onto. First, side effects differ between medicines and between people, so the clinic's own written information for each prescribed product is the reference that matters. Second, a side effect that is severe, worsening or simply worrying is always a valid reason to contact the clinic - the HFEA's advice is that fertility medication should only be taken under the care of a specialist, and a licensed physician is the right person to judge whether a symptom is routine or needs attention.

What is OHSS, and how is safety monitored during stimulation?

Ovarian hyperstimulation syndrome, or OHSS, is the main safety issue clinics watch for during stimulation. The ASRM describes it as an excessive response to the medicines used to make eggs grow, particularly in people undergoing IVF, with symptoms usually starting a few days after ovulation. In its mild form the ASRM describes abdominal bloating, nausea and weight gain due to fluid; in severe cases there can be persistent vomiting, significant swelling, shortness of breath and a risk of blood clots. The HFEA likewise lists OHSS as a recognised risk of gonadotrophin treatment and notes that in rare cases it can be serious. This is precisely why cycles are monitored so closely with scans and blood tests, and why physicians adjust plans mid-cycle - the ASRM lists strategies such as changing the trigger medicine and freezing embryos to delay transfer when a strong response is developing. The ASRM also notes that symptoms usually resolve within a couple of weeks unless pregnancy occurs, in which case they can last longer. Anyone in treatment who develops difficulty breathing, vomiting that will not settle, inability to keep fluids down, rapid weight gain, marked abdominal swelling or reduced urination should contact their clinic or a licensed physician promptly rather than waiting for a scheduled appointment. Useful questions to bring to a consultation with a licensed physician include:

  • Which medication protocol are you recommending for me, and why that one rather than the alternatives?
  • Which of my medicines will I inject at home, and who will teach me the technique before I start?
  • How will you monitor my response during stimulation, and how might my plan change based on the results?
  • What are the exact timing instructions for my trigger injection, and what should I do if I make a mistake with it?
  • What form of progesterone will I use after transfer, and how long should I expect to continue it?
  • Which symptoms should prompt me to call the clinic immediately, and how do I reach someone out of hours?
  • Are there any interactions between these medicines and anything else I currently take that we should review together?

SOURCES

Sources and review method

Editorially reviewed against the sources below on 25 August 2026. Choosing, prescribing and adjusting fertility medication requires a licensed physician who knows your history.

  1. HFEA (UK regulator)Fertility drugs

    Supports the statements that gonadotrophins are hormones injected into the body to help stimulate egg production, that clomifene citrate stimulates the ovaries to produce more eggs, that possible side effects of fertility drugs include stomach pains or a bloated stomach, hot flushes, mood swings, breast tenderness, headaches and insomnia, that gonadotrophins carry a risk of ovarian hyperstimulation syndrome which can in rare cases be serious, and that medication should only be taken under the care of a specialist.

  2. HFEA (UK regulator)In vitro fertilisation (IVF)

    Supports the statements that natural hormone production may be suppressed with a daily injection or nasal spray before stimulation, that hormone treatment (usually a gonadotrophin) is started to boost the number of eggs the body produces, that patients are closely monitored by the clinic which may involve blood tests or ultrasound scans, that an alternative approach uses an antagonist to suppress hormones for a few days after the stimulation medicine has begun, that medication to prepare the lining of the womb is usually taken as a pessary or gel a person can insert themselves, and that ovarian hyperstimulation syndrome is listed as a risk of treatment.

  3. ASRM / ReproductiveFacts.orgSide effects of injectable fertility drugs (gonadotropins) patient education fact sheet

    Supports the statements that gonadotropins are fertility medications given by injection containing follicle-stimulating hormone alone or combined with luteinizing hormone, that they act on the ovaries to produce multiple follicles, and that some women experience breast tenderness, headaches, mood swings and local skin irritation at injection sites.

  4. ASRM / ReproductiveFacts.orgMedications for inducing ovulation patient education fact sheet

    Supports the statements that clomiphene works by causing the pituitary gland to make more FSH, that letrozole temporarily decreases estradiol which prompts increased FSH production, that an injection of hCG mimics the natural LH surge and causes the follicle to release its egg, that GnRH agonists and antagonists prevent spontaneous ovulation by suppressing FSH and LH (agonists causing an initial rise before suppression while antagonists suppress immediately), that longer agonist use can cause temporary menopausal-type symptoms such as hot flashes, mood swings and vaginal dryness, and that residual hCG after the trigger injection can affect a pregnancy test taken soon afterwards.

  5. ASRM / ReproductiveFacts.orgOvarian hyperstimulation syndrome (OHSS) patient education fact sheet

    Supports the statements that OHSS is an excessive response to the medicines used to make eggs grow, particularly in individuals undergoing IVF, that symptoms usually start a few days after ovulation, that mild OHSS involves abdominal bloating, nausea and weight gain due to fluid, that severe OHSS can involve persistent vomiting, shortness of breath and blood clots, that patients should notify their doctor for symptoms including difficulty breathing, continued vomiting, inability to tolerate fluids, decreased urination and rapid weight gain, that prevention strategies include changing the trigger medicine and freezing embryos to delay transfer, and that symptoms usually resolve within about two weeks unless pregnancy occurs, in which case they often continue longer.

CONTINUE LEARNING

Continue reading

IVF Process & TechnologyConsidering IVF? Start with these seven key stagesFertility TestingWhat fertility tests are done before IVF? A plain-language guideTreatment PreparationHow to prepare for embryo transfer: a plain-language guide to transfer day